Viewing Study NCT05508412


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2025-12-31 @ 5:06 PM
Study NCT ID: NCT05508412
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-17
First Post: 2022-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cancer Patient Empowerment Program: Phase 2 Feasibility Study
Sponsor: Nova Scotia Health Authority
Organization:

Study Overview

Official Title: CancerPEP Phase 2 Randomized Trial: Feasibility of a Comprehensive Cancer Patient Empowerment Program Providing Immediate Versus Delayed Stress Reduction Biofeedback Equipment
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CancerPEP
Brief Summary: The Cancer Patient Empowerment Program is a comprehensive health promotion program aiming to improve the quality of life as well as both physical and mental health in cancer patients and survivors. The program includes daily email communications over 6 months that encourage strength and aerobic exercise, yoga, stress reduction techniques, dietary improvements, and more.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: